baber/WOPTO huggingface dataset:
Patent DK-1642627-T3 (DK)
Inventor: KROON ALBERT LOUISITO PHILLIPUS
IPC: A63G27/00
Filed: 2005-09-30
Granted: 2009-08-24
Abstract: A support installation for a fairground attraction, comprises a base (5), two pairs of masts (2) which can be moved between a collapsed and an erected position, as well as a head (3) that in the erected position is at the top of the masts, on which head a Ferris wheel (4) or a swing (8) or the like can be mounted, wherein the masts each comprise several segments (6,7) that are joined to one another such that they can pivot. Each mast has a base segment (6) that is joined to the base (5) such that it can pivot, as well as a top segment (7) that is joined to the head (3), at least in the erected position.
Patent DK-1778236-T3 (DK)
Inventor: CLARK ROBIN D
IPC: A61K31/506
Filed: 2005-06-29
Granted: 2010-10-25
Abstract: The present invention provides a class of modified pyrimidine compounds, compositions and methods of using the compounds as glucocorticoid receptor modulators.
Patent DK-1794173-T3 (DK)
Inventor: MILLAR DOUGLAS SPENCER
IPC: C07H21/00
Filed: 2005-09-09
Granted: 2010-10-25
Abstract: An amplification blocker comprising an intercalating nucleic acid (INA) containing two or more internal intercalating pseudonucleotides (IPNs) capable of blocking or reducing nucleic acid amplification. Use of the amplification blocker to block or reduce nucleic acid amplification.
Patent DK-1765362-T3 (DK)
Inventor: FRIEDLANDER MARTIN
IPC: A61K38/19
Filed: 2005-06-06
Granted: 2012-05-14
Abstract: The present invention provides compositions and methods of treating neovascular diseases, such as a retinal neovascular diseases and tumors, by administering to a patient suffering from a neovascular disease or tumor a vascular development inhibiting amount of a combination of the angiogenesis suppressing drugs comprising an angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS) and at least one compound selected from the group consisting of a vascular endothelial growth factor (VEGF) signaling inhibitor and an integrin signaling inhibitor. Compositions for use in the methods include an admixture of an angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS) and at least one of a vascular endothelial growth factor (VEGF) signaling inhibitor and an integrin signaling inhibitor, together with a pharmaceutically acceptable excipient.
Patent DK-1786867-T3 (DK)
Inventor: COSMAN MICHAEL A
IPC: C08L81/02
Filed: 2005-09-02
Granted: 2008-06-02
Abstract: Preformed compositions in shaped form comprising polymer blends, and the use of these preformed compositions in shaped form to seal apertures are disclosed. In certain embodiments, the preformed compositions are electrically conductive and are capable of shielding EMI/RFI radiation. The polymer blend includes a polysulfide component and a polythioether component.
Patent DK-2031237-T3 (DK)
Inventor: SCHULZ REINER DR
IPC: F02M61/16
Filed: 2008-07-21
Granted: 2011-01-10
Abstract: The nozzle (10) has a nozzle head (3) with nozzle outlets (4.1, 4.2) for injecting fuel into a combustion chamber of a diesel engine. An injection valve has a valve needle (6) and a valve seat (7), which is connected with the outlets by passages (5.1, 5.2). The valve seat cooperates with the valve needle for controlling fuel supply to the outlets. An emptying device e.g. compressed air reservoir (15), is provided for emptying the passages. A line (17) is connected with the emptying device and maintains connection with one passage to empty the passage during closing the injection valve.
Patent DK-2236533-T3 (DK)
Inventor: BURCKHARDT URS
IPC: C08G18/10
Filed: 2009-03-31
Granted: 2012-02-20
Abstract: Curable composition comprises (a) at least one blocked amine comprising a blocked, hydrolytically activatable amino group or at least one reactive group, which comprises hydroxyl-, mercapto- or secondary amino-groups; (b) at least one surface-deactivated polyisocyanate that is solid at room temperature; and (c) optionally water or a water-producing substance. Independent claims are included for bonding of a substrate-S1 with a substrate-S2 comprising either applying the curable composition on the substrates-S1 and -S2, contacting the applied composition together, and heating the applied composition at 60-160 (preferably 90-130)[deg] C, or heating the curable composition at 60-160 (preferably 90-130)[deg] C, applying the heated composition on the substrate-S1, contacting the applied composition with the substrate-S2 within the open time of the composition or applying the heated composition on the substrates-S1 and -S2, and contacting the applying composition together with the open time of the composition, where the substrate-S1 is same or different from -S2 and the time duration between the heating and the application of the composition is few minutes to some days or several weeks.
Patent DK-2459216-T3 (DK)
Inventor: SINGH MANMOHAN
IPC: A61K31/4375
Filed: 2010-09-01
Granted: 2013-12-09
Abstract: The invention provides a novel class of compounds, immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with Toll-Like Receptors 7. In one aspect, the compounds are useful as adjuvants for enhancing the effectiveness of a vaccine.
Patent DK-2371848-T3 (DK)
Inventor: Türeci Özlem
IPC: C07K16/30
Filed: 2005-05-18
Granted: 2018-07-23
Abstract: Pharmaceutical composition comprising nucleic acid with specific sequence, useful for inhibiting expression or activity of tumor-associated antigen, where the tumor associated antigen has a fully defined nucleic acid sequence. The nucleic acid is alternatively one which, under stringent conditions hybridizes, is degenerated with respect to, or is complementary to the foregoing. Pharmaceutical composition comprising nucleic acid with specific sequence, useful for inhibiting expression or activity of tumor-associated antigen, where the tumor associated antigen has a nucleic acid-coded sequence selected from the group comprising sequence identification numbers 1-8, 41-44, 51-59, 84, 117, 119 and 138, a part or derivative of them. The nucleic acid is alternatively one which, under stringent conditions hybridizes, is degenerated with respect to, or is complementary to the foregoing. The composition or agent so determined, is selective for cells which exhibit expression or abnormal expression of a tumor-associated antigen. The agent induces cell death, reduction of cell growth, damage to the cell membrane or secretion of cytokines. Numerous developments and variations in accordance with the foregoing principles are elaborated. Independent claims are included for the following: (1) a method of disease diagnosis; (2) a kit for the purpose of disease diagnosis; (3) a nucleic acid or associated recombinant DNA or RNA molecule; (4) a host cell; (5) a protein, polypeptide; and (6) an immunogenic fragment, antibody or conjugate. ACTIVITY : Cytostatic. MECHANISM OF ACTION : Tumor associated antigen inhibitor.
Patent DK-2941967-T3 (DK)
Inventor: KANG KYUNG II
IPC: A23L11/20
Filed: 2015-05-08
Granted: 2018-01-08
Abstract: An improved method for producing fermented soybean meal which performs fermentation process and drying process separately in the production of the fermented soybean meal. The method for preparing fermented soybean meal enables prevention of contamination by various germs while shortening the time required for its preparation compared to the conventional method. Therefore, the method can be widely used to more economically prepare the fermented soybean meal.
Patent DK-3169666-T3 (DK)
Inventor: KÜHNERT SVEN
IPC: C07D209/96
Filed: 2015-07-14
Granted: 2018-07-30
Abstract: The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the μ opioid receptor and/or the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.
Patent DK-0392208-T3 (DK)
Inventor: WOLFF ERNST
IPC: B65D35/50
Filed: 1990-03-15
Granted: 1993-09-27
Abstract: In order to provide a container (1), which is operationally reliable in handling and can be produced economically, in the form of a tube or bottle with a neck (2), in whose end face (9) the removal opening (3) is arranged, which can be closed by a lid (5) which is held against its seat in the closed position by a restoring element arranged in the interior of the container (1), the restoring element being constructed in such a way that its force is less than a force caused by a pressing-on pressure exerted on the contents of the container, the lid (5), being axially movable and constructed in a conical shape or in the shape of a calotte shell, is arranged in a correspondingly shaped seat in the end face (9) of the removal opening and the restoring element is constructed as a spring (4) which is connected to the lid (5) via a pulling element (8). <IMAGE>
Patent DK-0405525-T3 (DK)
Inventor: MORITA TOMINORI
IPC: A61P9/08
Filed: 1990-06-27
Granted: 1994-10-17
Abstract: Compounds of the formula: <CHEM> wherein R<1> and R<2> are independently fluorine, chlorine or bromine atom, and R<3> is a C4-C7 alkyl having at least a branch at the C1 position, exhibit K<+> channel opening activity and are useful as hypotensive agents and coronary vasodilators.
Patent DK-0425795-T3 (DK)
Inventor: REIL WILHELM
IPC: B65B3/02
Filed: 1990-09-08
Granted: 1994-01-31
Abstract: A machine is described for making milk packages which in each case have a tubular body made of coated paper, with devices (5) for forming the tubular body and devices for spraying plastic onto the tubular body, with a conveyor belt (12) which runs along the treatment path and which holds a series of cross-sectionally rectangular conveying containers (13), with devices for introducing the tubular body into the respective conveying container (13) and with devices (16) for removing and transporting away the treated tubular body. 
<??>To increase the capacity of the package making machine, in order in particular that the spraying tools can be opened and closed more quickly, it is proposed according to the invention that a first part (12'') at least of one section of the continuously circulating conveyor belt (12) runs arranged at a fixed angle ( alpha ) of preferably approximately 45 DEG  in relation to the second part (12''') of this section, that a side wall of a conveying container (13) is arranged parallel to the main plane of the flat conveyor belt (12) and that rails for guiding the conveyor belt (12) are fastened along its conveying path. 
<IMAGE>
Patent DK-0413386-T3 (DK)
Inventor: BUSER ANTONIUS JOHANNES WILHEL
IPC: C08F283/10
Filed: 1990-08-08
Granted: 1994-08-08
Abstract: Disclosed are polymeric materials comprising an interpenetrating network (IPN) prepared from cyclic moieties-containing allyl polymers and epoxy resins. The allyl polymers art crosslinked under the influence of a radical initiator, the epoxy resin is crosslinked by a curing agent. The curing agent is a polyhydric phenol or a cyclic anhydride not containing a polymerizable double bond. Preferably the curing agent is bisphenol-A or tetrabromo-bisphenol-A. Preferred IPN's are prepared from triallylcyanurate-based allyl polymers and phenol-type epoxy resin.
Patent DK-0382431-T3 (DK)
Inventor: HILL ALAN MICHAEL
IPC: H04M3/00
Filed: 1990-02-02
Granted: 1995-02-13
Abstract: A communications network in which a central switching node (70) has at least two sets of both input ports (52) and output port (56) coupled to respective sets of transmitters (Tij) and receivers (Rij) by passive optical networks (54) and (58) and demultiplexers (52) and multiplexers (59). The transmitters (Tij) are tunable so that each can be selectively coupled to one of the input ports (52). The receivers (Rij) are also tunable so the output ports (56) can be selectively coupled to the one or more of the receivers (Rij). Alternatively, the demultiplexers (55) and multiplexers (59) can be tunable. This devolves some of the switching function outside the central switching node (50) thereby reducing the component count.
Patent DK-0421956-T3 (DK)
Inventor: LEO FRANCA
IPC: A23K1/00
Filed: 1990-10-02
Granted: 1994-01-24
Abstract: A food product for dogs and cats consists of a paste of meat, vegetables, eggs, mineral salts, maize flour, soya lecithin, milk or its derivatives, which is subsequently moulded to a desired shape. The product thus shaped is then freeze dried.
Patent DK-0472033-T3 (DK)
Inventor: HORST CLAUS DR RER NAT DIPL-BI
IPC: A61K31/195
Filed: 1991-08-02
Granted: 1996-01-29
Abstract: The composition for TSH suppression and treatment of goitre contains a therapeutically effective dose of 3,5-diiodo-L-thyronine and conventional pharmaceutical aids. The metabolite, which has hitherto been regarded as of low activity, displays on long-term administration a potent action on the TSH level without unwanted side effects.
Patent DK-0498093-T3 (DK)
Inventor: BROWN DAVID L
IPC: A61B17/06
Filed: 1991-02-01
Granted: 1996-02-05
Abstract: A package (10) is provided for a combined surgical suture (39)- needle (40) device featuring a peelable, or strippable, closure flap (20). <IMAGE>
Patent DK-0446003-T3 (DK)
Inventor: ASHWORTH PAUL
IPC: C07C69/76
Filed: 1991-03-04
Granted: 1994-10-03
Abstract: Flame retardant polyesters are disclosed comprising esters of tri-bromoneopentyl alcohol with orthophthalic acid and its halogenated derivatives, particularly tetrabromo-orthophthalic acid.
Patent DK-0465427-T3 (DK)
Inventor: DESTEFANI GIORGIO
IPC: B61D17/04
Filed: 1991-07-01
Granted: 1996-04-09
Abstract: The coach body construction comprises an upper structure having extruded profiles, which are connected detachably to one another by corner connectors and are made of an aluminum alloy, and a lower structure. The lower structure is composed of longitudinal and transverse supports which are made of an extruded aluminum alloy and are detachably connected to one another and to the upper structure by corner connectors. In interaction with the upper structure, it is of inherently sturdy construction. The corner connectors are, in particular, screw-on corner connectors.
Patent DK-0484468-T3 (DK)
Inventor: GUGLIELMI GUIDO
IPC: A61B17/00
Filed: 1991-01-03
Granted: 1999-11-22
Abstract: A guidewire (10,42) for use in endovascular electrothrombosis in combination with a microcatheter (44), the guidewire comprising:a core wire having a main body (12,16;32) and a distal portion (18,26;36,46); anda coil (28,56) coupled to said main body (12,16,32) via said distal portion (18,26,36,46) and comprised of material not susceptible to electrolytic disintegration in blood, said coil (28,56) containing no internal reinforcement and being for endovascular insertion within a vascular cavity;   wherein said distal portion (18,26,36,46) is susceptible to electrolytic disintegration in blood whereby, on the application of current to the guidewire (10,42) when said coil (28,56) is disposed in the vascular cavity, endovascular electrothrombosis can be performed and at least one portion of said distal portion (18,26,36,46) electrolytically disintegrated to detach said coil (28,56) from said main body (12,16,32).
Patent DK-0535231-T3 (DK)
Inventor: UEDA TOHRU
IPC: C07H23/00
Filed: 1991-06-13
Granted: 1995-08-21
Abstract: A novel pyrimidine nucleoside derivative of formula (1) or (2) and a salt thereof, wherein R<1> represents amino which may be substituted with hydroxy or acyl; R<2> represents hydrogen or C<5> to C<8> alkyl; R<3> represents hydrogen or hydroxy; and R4 and R5 represent each hydrogen or they may be combined together to represent -R6R<6'>Si-O-SiR7R<7'>-, wherein R6, R<6'>, R7 and R<7'> each represents lower alkyl. This compound has an excellent antitumor effect or serves as a useful intermediate for the synthesis of antitumor drugs. <CHEM>
Patent DK-0609242-T3 (DK)
Inventor: BIALOJAN SIEGFRIED
IPC: C12R1/19
Filed: 1992-09-21
Granted: 1997-01-06
Abstract: Described is a new thrombin-inhibiting protein isolated from ticks, with a molecular weight of about 8000 Daltons and the N-terminus Leu-Asn-Val-Leu-Cys-Asn-Asn-Pro-His-Thr-Ala-Asp-Cys-Asn-Asn-Asp-Ala-Gln-Val-Asp. The protein is suitable for use in the treatment of illnesses.
Patent DK-0561467-T3 (DK)
Inventor: GOGLIO ALFEO
IPC: F16L55/16
Filed: 1993-03-17
Granted: 1996-10-14
Abstract: A method for repairing local damage (2) to pipelines (1) by applying a cylindrical cladding consisting of two cylindrical half-shells (3,4) welded together to create an interspace, which is sealed by applying gaskets forced against the circular edges Of the cladding, after which resin is injected into the interspace at high pressure. <IMAGE>
Patent DK-0626974-T3 (DK)
Inventor: ZIMMERMANN ULRICH
IPC: A61K6/90
Filed: 1993-02-12
Granted: 1997-06-23
Abstract: PCT No. PCT/DE93/00136 Sec. 371 Date Aug. 10, 1994 Sec. 102(e) Date Aug. 10, 1994 PCT Filed Feb. 12, 1993 PCT Pub. No. WO93/16111 PCT Pub. Date Aug. 19, 1993Proposed is a mitogen-free substance comprising cross-linked copolymers including 10 to 90 mole % of guluronic acid, the balance being made up of mannuronic acid. The substance has a molecular weight of from 10,000 to 500,000 Daltons. Also proposed are methods for preparing such substances and their use.
Patent DK-0634920-T3 (DK)
Inventor: PERRY BRUCE FRANKLIN
IPC: A61F13/15
Filed: 1993-03-22
Granted: 1998-03-02
Abstract: A polymeric multilayer film having a high percentage of fillers to increase the opacity of the film is disclosed. The fillers are concentrated in a separate filler containing layer having about 20 to about 60 weight percent fillers uniformly dispersed therein and about 30 to about 70 percent of the thickness of the total multilayer film. The filler containing layer is coextruded with the outer layers comprising the balance of the thickness of the multilayer film. The multilayer film has at least 15 weight percent fillers.
Patent DK-0650446-T3 (DK)
Inventor: PRZYTULLA DIETMAR
IPC: B65D51/16
Filed: 1993-06-30
Granted: 1997-03-24
Abstract: The invention relates to a threaded plug (10) with an outside diameter of 100 mm or more for large containers, especially large pallet containers with a capacity of, for example, 1000 l, intended for the transport of gassing or outgassing substances. In order to prevent the undesirable formation of internal pressure in the container, there is an aperture (16) with an outgassing device (24) in the middle of the disc-shaped top (12) of the threaded plug (10) which is designed in such a way that it is impossible for a higher vapour pressure than 0.3 bar to form in the gas phase above the fluid content.
Patent DK-0615048-T3 (DK)
Inventor: REICHERT RAINER
IPC: E06B3/00
Filed: 1994-01-21
Granted: 1999-02-22
Abstract: The bottom part of the housing also forms the top cross-member of a window- or door-frame, and consists of an angle-section rail (12). This extends from an upwards-inclined wall-section (22) via a narrow vertical rib (23) to the housing cover (11). The top member (26) of the hinging window (8) or door has a chamfer (17) or curved face between its inner vertical and horizontal walls matching that (30) on the rail.The width of the vertical rib (23) can be less than one-third of the overall rail width, and it can be hollow, containing a profiled reinforcing member. It can extend away from the rail roughly in a horizontal plane through the lengthwise axis (31) of the shutter winding shaft.
Patent DK-0705263-T3 (DK)
Inventor: EDWARDS CARL K III
IPC: A61P11/00
Filed: 1994-05-25
Granted: 1997-05-05
Abstract: The present invention relates to compounds of the formulawhereinX is N3, NH2, NHR, N(R)2, CN, SH, SR, or OR1; R is C1-C4 alkyl or (CH2)n-phi; n is an integer 0, 1, 2, 3 or 4; phi is a phenyl group unsubstituted or substituted with from 1 to 3 substituents, each substituent is independently selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, halogen, CF3, OCF3, OH, CN, NO2 or NH2; R1 is C1-C4 alkyl or (CH2)m-NR2R3; m is an integer 1, 2, 3 or 4; R2 and R3 are each independently C1-C4 fluorinated akyl or cycloalkyl;The X substituent on the cyclopentanyl ring is in the TRANS configuration relative to the bicyclic substituent;Y is nitrogen;Z1 and Z2 are each independently hydrogen, halogen or NH2; and---- represents a singe or double bond;or pharmaceutically acceptable salts thereof, compositions comprising such compounds, and methods of treatment comprising administering of such compounds.
Patent DK-0749264-T3 (DK)
Inventor: GAIDAROV ALEXANDR SERGEEVICH
IPC: H04R5/00
Filed: 1994-08-05
Granted: 2003-03-24
Abstract: The proposed loudspeaker comprises at least one two-aperture source unit (1) which has a pair of identical co-phase, counter-emitting apertures (4) and reproduces mid-range frequencies. The apertures (4) directly face each other, their geometrical axis F is vertical, while the distance between the two apertures (4) is not less than the radius of each aperture (4) and not greater than the wavelength corresponding to the lowest frequency reproducible by the pair of apertures (4). <IMAGE>
Patent DK-0672752-T3 (DK)
Inventor: SAITO HIDEAKI
IPC: C12N15/82
Filed: 1994-09-01
Granted: 2004-10-04
Abstract: A method of transforming a monocotyledon which, as compared with the conventional methods, is shortened in the period from the transformation to the regeneration of a plant body, can generally be applied to a plant for which a means for regenerating a plant body from the protoplast is not established as yet, and can dispense with special apparatus, and for which necessary materials are readily available. The method comprises transforming a scutellum of a non-dedifferentiated immature embryo of a monocotyledon with an agrobacterium. <IMAGE>
Patent DK-0720745-T3 (DK)
Inventor: CARROLL STEPHEN FITZHUGH
IPC: G01N33/564
Filed: 1994-09-22
Granted: 1999-06-23
Abstract: The present invention provides a method for quantifying the presence of extracellular BPI in body fluids including blood in a subject comprising conducting a BPI immunoassay on body fluid sample obtained from said subject.
Patent DK-0788549-T3 (DK)
Inventor: FRIEDMANN ANNICK
IPC: C12P21/02
Filed: 1994-12-05
Granted: 2005-02-14
Abstract: PCT No. PCT/FR94/01413 Sec. 371 Date Jun. 7, 1996 Sec. 102(e) Date Jun. 7, 1996 PCT Filed Dec. 5, 1994 PCT Pub. No. WO95/16046 PCT Pub. Date Jun. 15, 1995Novel nucleic acid sequences, vectors for expressing same, and uses of said sequences, in particular in actinomycetes fermentation methods.
Patent DK-0830299-T3 (DK)
Inventor: SCHULTCHEN ARNE JACOB
IPC: B65D85/18
Filed: 1996-05-31
Granted: 1999-08-23
Abstract: PCT No. PCT/EP96/02351 Sec. 371 Date Feb. 19, 1998 Sec. 102(e) Date Feb. 19, 1998 PCT Filed May 31, 1996 PCT Pub. No. WO96/39344 PCT Pub. Date Dec. 12, 1996The invention concerns a container made from a cardboard blank and intended for articles of clothing, in particular pullovers, T-shirts and the like. It comprises a front section with a flap section joined by an intermediate section via fold lines, a rear section with a flap section joined via a fold line, and an intermediate section which connects the front section and rear section and is provided with a grip- or view-hole. The front section is provided in one of its edge regions with a pop-up flap unit formed by an incompletely closed cut line, preferably an arc of about 300 DEG .
Patent DK-0874642-T3 (DK)
Inventor: RUIZ JEAN-MARC
IPC: A61K47/44
Filed: 1997-01-15
Granted: 2003-08-11
Abstract: A sustained release drug formulation including: a drug; a biodegradable polymer which is insoluble in water; and an oil vehicle in which both the drug and the polymer are dissolved. The oil vehicle contains 10-100% by volume a pharmaceutically acceptable oil and 0-90% by volume a pharmaceutically acceptable liquid carrier for the drug or the polymer.